Cargando…
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study
Health-related quality of life (HRQoL) is impaired in HIV/HCV-coinfected patients (HIV/HCV) and further decreased by interferon (IFN)-based therapies. We aimed to investigate the impact of IFN- and ribavirin (RBV)-free therapies on HRQoL and fatigue. Thirty-three HIV/HCV-coinfected patients who unde...
Autores principales: | Scheiner, Bernhard, Schwabl, Philipp, Steiner, Sebastian, Bucsics, Theresa, Chromy, David, Aichelburg, Maximilian C., Grabmeier-Pfistershammer, Katharina, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas, Mandorfer, Mattias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058819/ https://www.ncbi.nlm.nih.gov/pubmed/27399090 http://dx.doi.org/10.1097/MD.0000000000004061 |
Ejemplares similares
-
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients
por: Chromy, David, et al.
Publicado: (2017) -
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017) -
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
por: Scheiner, Bernhard, et al.
Publicado: (2015) -
The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022) -
The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)